30 January
The highly anticipated kick-off meeting of the BIOTOOL-CHF Project took place over two days, January 29 and 30, 2024. The meeting was hosted at the prestigious IRCCS Policlinico di Sant’Orsola – Azienda Ospedaliero Universitaria di Bologna and brilliantly coordinated by Dr. Luciano Potena, who also serves as the Project Coordinator. The meeting served as a pivotal moment for all 23 consortium partners to come together and see the take-off of this ambitious project.
During the intensive sessions in the wonderful city of of Bologna, participants engaged in comprehensive discussions regarding the project’s objectives and methodologies. Delving into the specifics of the work packages outlined, each partner had the opportunity to introduce themselves and outline their respective roles within the consortium.
The BIOTOOL-CHF Project aims to revolutionize the management of heart failure (HF), a chronic clinical condition affecting millions across the whole Europe. With HF being a leading cause of hospitalization and associated with high mortality rates, there is an urgent need for more effective treatment strategies. At the core of the project lies the development and validation of innovative tools and methodologies to address the challenges in HF management. From validating biomarkers for estimating congestion to leveraging artificial intelligence for predictive modeling, the project seeks to enhance clinical decision-making and improve patient outcomes.
Additionally, the project will develop a decision-making tool to guide the management of congestion using diuretics, along with a Point of Care companion diagnostic (CD) to assess biomarker concentrations. By integrating new tools and digital solutions, BIOTOOL-CHF aims to personalize the management of HF and optimize the use of existing pharmaceuticals.
As the kick-off meeting concludes, the BIOTOOL-CHF Project looks ahead to the next phase of its journey, driven by a shared commitment to innovation and collaboration in tackling the challenges of heart failure.